Despite immune suppression via hypoxia, metabolic competition, insufficient CD4+ T cells, and high expression of regulatory molecules (e.g., VEGF, CXCL17, IL-10, IDO), the presence of CD8+ CTLs in HCC correlates with improved survival (32–37). This evidence concerns the gene CD4 and hepatocellular carcinoma.